Leanne Kelly - 02 Jun 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Financial Officer
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
02 Jun 2021
Net transactions value
+$25,175
Form type
4
Filing time
04 Jun 2021, 16:06:09 UTC
Previous filing
18 May 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRI Common Stock Purchase $14,628 +3,657 $4.00 3,657 02 Jun 2021 Direct
transaction GRI Common Stock Purchase $4,394 +1,085 +30% $4.05 4,742 03 Jun 2021 Direct
transaction GRI Common Stock Purchase $6,153 +1,508 +32% $4.08 6,250 04 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.